

| 货号 | ICH8015 |
|---|---|
| 品牌 | IchorBio |
| 描述 |
Mirikizumab PK ELISA Kit (ICH8015) is a antibody targeting IL-23 (p19 subunit). Validated for PK ELISA.
Highlights
|
| 应用 | PK ELISA |
| 克隆类型 | Monoclonal |
| 经测试应用 | PK ELISA |
| 靶标 | IL-23 (p19 subunit) |
| Accession号 | Q9NPF7 |
| 状态 | Liquid |
| 保存溶液 | Pre-coated 96-well plate, standards, detection antibody, streptavidin-HRP, buffers Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 运输 | Blue Ice |
| 稳定性和存储 | The ELISA Kit should be stored at 2–8°C and is stable for up to 6 months when unopened, unless otherwise stated on the product label or datasheet. Components stored separately may remain stable for up to 12 months under recommended conditions. After opening, keep components tightly capped at 2–8°C. Prepared working solutions should be used on the day of preparation, and repeated freeze-thaw cycles of protein-containing reagents, including reconstituted standards/calibrators, should be avoided. |
| 规格 | Size: 96T |
| 别名 | LY-3074828, 1884201-71-1 |
| 背景 | Mirikizumab is a monoclonal antibody targeting interleukin-23 (IL-23), a central cytokine in the Th17 inflammatory pathway. By selectively inhibiting IL-23 signaling, this antibody reduces downstream production of proinflammatory cytokines such as IL-17, thereby attenuating chronic inflammation. This class of IL-23 inhibitors is used primarily in the treatment of psoriasis and other immune-mediated inflammatory diseases, where dysregulated Th17 responses drive pathology. |
| Note | For research only |

24小时产品查询

扫一扫关注我们

专属渠道经理